Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants

Vaccine

Volumn 17, Issue 18, 1999, Pages 2259-2264

  Sohn, Young Mo ^a   Park, Min Soo ^a   Rho, Hye Ok ^a   Chandler, Laura J ^b   Shope, Robert E ^b   Tsai, Theodore F ^c  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN M; INACTIVATED VIRUS VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; KOREA; LICENCE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; VACCINATION; VACCINE PRODUCTION; VIRUS ATTENUATION;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; ENCEPHALITIS VIRUSES, JAPANESE; ENCEPHALITIS, ARBOVIRUS; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN M; INFANT; VACCINES, ATTENUATED; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0344758398     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00006-7     Document Type: Article

References (15)

1. Rojanasuphot S., Tsai T.F. Regional workshop on control strategies for Japanese encephalitis. Southeast Asian J. Trop. Med. Public Health. 26(Suppl. 3):1994;1-59.
2. Tsai, TF, Chang, GJ, Yu, YX, Japanese encephalitis vaccines. In: Plotkin, SE and Orenstein, W, editors. Vaccines, third edition. Phila, PA, WB Saunders, 1999:672 - 710.
3. Plesner A.M., Ronne T. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. Vaccine. 15:1997;1293-1343.
4. Berg S.W., Mitchell B.S., Hanson R.K.et al. Systemic reactions in US Marine Corps personnel who received Japanese encephalitis vaccine. J. Infect. Dis. 24:1997;265-266.
5. Hennessy S., Liu Z., Tsai T.F.et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet. 347:1996;1583-1586.
6. Tsai, TF, Arboviruses. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology, seventh edition. American Soc for Microbiol Washington DC, 1999:1107 - 1124.
7. Burke D.S., Nisalak A., Ussery M.A., Laorakpongse T., Chantavibul S. Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J. Infect. Dis. 151:1985;1093-1099.
8. Liu Z.L., Hennessy S., Strom B.L.et al. Short-term safety of live-attenuated Japanese encephalitis vaccine (SA14-14-2): results of a 26,239-subject randomized clinical trial. J. Infect. Dis. 176:1997;1366-1369.
9. Yu Y.X., Ming A.G., Pen G.Y.et al. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am. J. Trop. Med. Hyg. 39:1988;214-217.
10. Tsai T.F., Yu Y.X., Jia L.L.et al. Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine - a comparison of 1- and 3-month immunization schedules. J. Infect. Dis. 177:1998;221-223.
11. Monath, TP, Yellow fever vaccine. In: Plotkin, S, Orenstein, W, editors. Vaccines, third edition, Phila, PA, WB Saunders (in press).
12. Poland J.D., Cropp C.B., Craven R.B., Monath T.P. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J. Infect. Dis. 161:1990;878-882.
13. Centers for Disease Control. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). 1993; Morb Mortal Wkly Rep 42(No. RR-1):1-15.
14. Hoke C.H., Nisalak A., Sangawhipa N.et al. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319:1989;609-614.
15. Ni H., Barrett A.D. Nucleotide and deduced amino acid sequence of the structural protein genes of Japanese encephalitis viruses from different geographical locations. J. Gen. Virol. 76:1995;401-407.